Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-24-006102
Filing Date
2024-02-13
Accepted
2024-02-13 16:30:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 130478
  Complete submission text file 0001493152-24-006102.txt   132400
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Subject) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45947 | Film No.: 24626562
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 2128473500
GOLDENTREE ASSET MANAGEMENT LP (Filed by) CIK: 0001278951 (see all company filings)

EIN.: 134118850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A